{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:08:33Z","timestamp":1780434513685,"version":"3.54.1"},"reference-count":26,"publisher":"AACN Publishing","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,15]]},"abstract":"<jats:p>Coronary artery disease is the most common type of heart disease. Revascularization with coronary artery bypass grafting can improve survival in patients with severe coronary artery disease and reduced left ventricular ejection fraction. The Impella 5.5 (Abiomed) with SmartAssist intravascular microaxial blood pump can provide safe and effective perioperative support in patients with severely reduced left ventricular ejection fraction of less than 20%. However, no research has been conducted on Impella 5.5 use with patients who have left ventricular ejection fraction of less than 20% and persistent nonsustaining ventricular tachycardia. More research is needed on the use of the Impella device, specifically regarding patient profile, timing, and device management. This case report describes the outcomes of a 4-vessel coronary artery bypass grafting revascularization procedure assisted by Impella use and dobutamine in combination with antiarrhythmic agents for a patient with both severe coronary disease and persistent nonsustaining ventricular tachycardia postoperatively.<\/jats:p>","DOI":"10.4037\/aacnacc2026902","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T20:32:07Z","timestamp":1780432327000},"page":"167-172","source":"Crossref","is-referenced-by-count":0,"title":["Impella 5.5\u2013Assisted Coronary Arterial Bypass Graft in a Patient With Severe Reduced Left Ventricular Function: A Case Report"],"prefix":"10.4037","volume":"37","author":[{"given":"Hong","family":"Zhao","sequence":"first","affiliation":[{"name":"Hong Zhao is Acute Care Nurse Practitioner, Critical Care Medicine, Houston Methodist Sugar Land Hospital, 16655 Southwest Fwy, Sugar Land, TX, 77479 (hzhao2@houston-methodist.org)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2471","reference":[{"key":"2026060216320129800_b1-0370167","unstructured":"Centers for Disease Control and Prevention\n          . Heart disease facts. US Department of Health and Human Services. October\u200824, 2024. Accessed March 2, 2025. https:\/\/www.cdc.gov\/heart-disease\/data-research\/facts-stats\/index.html"},{"issue":"14","key":"2026060216320129800_b2-0370167","doi-asserted-by":"publisher","first-page":"e033938","DOI":"10.1161\/JAHA.123.033938","article-title":"Coronary artery disease is a stronger predictor of all-cause mortality than left ventricular ejection fraction among patients with newly diagnosed heart failure: insights from the WDHR","volume":"13","author":"Nielsen","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"2026060216320129800_b3-0370167","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.3390\/diagnostics12092233","article-title":"Coronary artery bypass graft surgery brings better benefits to heart failure hospitalization for patients with severe coronary artery disease and reduced ejection fraction","volume":"12","author":"Chen","year":"2022","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"2026060216320129800_b4-0370167","doi-asserted-by":"publisher","first-page":"e003255","DOI":"10.1161\/circheartfailure.116.003255","article-title":"Survival benefits of invasive versus conservative strategies in heart failure in patients with reduced ejection fraction and coronary artery disease: a meta-analysis","volume":"10","author":"Wolff","year":"2017","journal-title":"Circ Heart Fail"},{"key":"2026060216320129800_b5-0370167","unstructured":"Abiomed receives FDA PMA approval for Impella 5.5 with SmartAssist, a minimally invasive, forward flow heart pump. News release. September\u200825, 2019. Accessed March 24, 2026. https:\/\/www.abiomed.com\/en-us\/about-us\/news-and-media\/press-releases\/abiomed-receives-fda-pma-approval-impella-55-smartassist-minimally-invasive-forward"},{"key":"2026060216320129800_b6-0370167","doi-asserted-by":"publisher","first-page":"1018203","DOI":"10.3389\/fcvm.2023.1018203","article-title":"Single center experience and early outcomes of Impella 5.5","volume":"10","author":"Funamoto","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"2026060216320129800_b7-0370167","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13019-022-01871-1","article-title":"Single center first year experience and outcomes with Impella 5.5 left ventricular assist device","volume":"17","author":"Rock","year":"2022","journal-title":"J Cardiothorac Surg"},{"issue":"18","key":"2026060216320129800_b8-0370167","doi-asserted-by":"publisher","first-page":"5404","DOI":"10.3390\/jcm11185404","article-title":"Preventive Impella support in high-risk patients undergoing cardiac surgery","volume":"11","author":"Benke","year":"2022","journal-title":"J Clin Med"},{"key":"2026060216320129800_b9-0370167","unstructured":"Ventricular tachycardia. Mayo Clinic. March\u20086, 2024. Accessed March 5, 2025. https:\/\/www.mayoclinic.org\/diseases-conditions\/ventricular-tachycardia\/symptoms-causes\/syc-20355138"},{"issue":"2","key":"2026060216320129800_b10-0370167","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/icvts\/ivac088","article-title":"Impella support as a bridge to heart surgery in patients with cardiogenic shock","volume":"35","author":"Saito","year":"2022","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"2026060216320129800_b11-0370167","unstructured":"Impella 5.5 with SmartAssist for use during cardiogenic shock: instructions for use and clinical reference manual. Abiomed; 2019. https:\/\/bchcicu.org\/wp-content\/uploads\/2020\/10\/Impella_5.5_intrusction.pdf"},{"issue":"2","key":"2026060216320129800_b12-0370167","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/aor.14428","article-title":"Outcomes of systemic bivalirudin and sodium bicarbonate purge solution for Impella 5.5","volume":"47","author":"Bashline","year":"2023","journal-title":"Artif Organs"},{"issue":"11","key":"2026060216320129800_b13-0370167","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.healun.2025.06.008","article-title":"Clinical management of the Impella 5.5 pump","volume":"44","author":"Bernhardt","year":"2025","journal-title":"J Heart Lung Transplant"},{"issue":"10","key":"2026060216320129800_b14-0370167","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.3390\/life12101629","article-title":"Microaxial left ventricular assist device in cardiogenic shock: a systematic review and meta-analysis","volume":"12","author":"Tan","year":"2022","journal-title":"Life"},{"key":"2026060216320129800_b15-0370167","doi-asserted-by":"publisher","first-page":"e05","DOI":"10.15420\/icr.2021.11","article-title":"A review of the Impella devices","volume":"17","author":"Zein","year":"2022","journal-title":"Interv Cardiol"},{"issue":"17","key":"2026060216320129800_b16-0370167","doi-asserted-by":"publisher","first-page":"e030819","DOI":"10.1161\/JAHA.123.030819","article-title":"Complications and outcomes of Impella treatment in cardiogenic shock patients with and without acute myocardial infarction","volume":"12","author":"Saito","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2026060216320129800_b17-0370167","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.xjon.2023.06.015","article-title":"Temporary circulatory support with surgically implanted microaxial pumps in postcardiotomy cardiogenic shock following coronary artery bypass surgery","volume":"15","author":"Sommer","year":"2023","journal-title":"JTCVS Open"},{"key":"2026060216320129800_b18-0370167","unstructured":"Smith\u2008MD, Maani\u2008CV. Norepinephrine. In: StatPearls [Internet]. StatPearls Publishing. Updated December 11, 2024. Accessed March 7, 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK537259"},{"issue":"9","key":"2026060216320129800_b19-0370167","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.cjco.2021.03.015","article-title":"Refractory Impella suction alarms in the setting of extracorporeal membrane oxygenation","volume":"3","author":"Aoun","year":"2021","journal-title":"CJC Open"},{"issue":"2","key":"2026060216320129800_b20-0370167","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/HCO.0000000000001115","article-title":"A review of the contemporary use of inotropes in patients with heart failure","volume":"39","author":"Neicheril","year":"2024","journal-title":"Curr Opin Cardiol"},{"key":"2026060216320129800_b21-0370167","unstructured":"Ashkar\u2008H, Adnan\u2008G, Patel\u2008P, Makaryus\u2008AN. Dobutamine. In: StatPearls [Internet]. StatPearls Publishing. Updated February 23, 2024. Accessed March 7, 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470431"},{"key":"2026060216320129800_b22-0370167","doi-asserted-by":"publisher","first-page":"821938","DOI":"10.3389\/fcvm.2022.821938","article-title":"Effectiveness of amiodarone in preventing the occurrence of reperfusion ventricular fibrillation after the release of aortic cross-clamp in open-heart surgery patients: a meta-analysis","volume":"9","author":"He","year":"2022","journal-title":"Cardiovasc Med"},{"key":"2026060216320129800_b23-0370167","doi-asserted-by":"publisher","first-page":"1171956","DOI":"10.3389\/fcvm.2023.1171956","article-title":"Clinical outcomes and predictors of success with Impella weaning in cardiogenic shock: a single-center experience","volume":"10","author":"Matassini","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"2026060216320129800_b24-0370167","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s11010-020-04019-8","article-title":"Biochemical markers for clinical monitoring of tissue perfusion","volume":"476","author":"Janotka","year":"2021","journal-title":"Mol Cell Biochem"},{"issue":"17","key":"2026060216320129800_b25-0370167","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1093\/eurheartj\/ehaa1057","article-title":"Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score","volume":"42","author":"Younis","year":"2021","journal-title":"Eur Heart J"},{"issue":"5","key":"2026060216320129800_b26-0370167","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s40520-021-02019-2","article-title":"Secondary prevention implantable cardioverter-defibrillator (ICD) therapy: value in octogenarians","volume":"34","author":"Hauck","year":"2022","journal-title":"Aging Clin Exp Res"}],"container-title":["AACN Advanced Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacnjournals.org\/aacnacconline\/article-pdf\/37\/2\/167\/170605\/167.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacnjournals.org\/aacnacconline\/article-pdf\/37\/2\/167\/170605\/167.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T20:32:09Z","timestamp":1780432329000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacnjournals.org\/aacnacconline\/article\/37\/2\/167\/33052\/Impella-5-5-Assisted-Coronary-Arterial-Bypass"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6,15]]}},"URL":"https:\/\/doi.org\/10.4037\/aacnacc2026902","relation":{},"ISSN":["1559-7768","1559-7776"],"issn-type":[{"value":"1559-7768","type":"print"},{"value":"1559-7776","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]}}}